THE TRINITY MEDICAL PRACTICE — All Prescriptions & Medications — Page 2
Practice Code: F81751 | CHELMSFORD, CM3 6AB
Showing results 51-100 of 512
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Rosuvastatin calcium | 558 | 14.5K | £782 | -37.8% ▼ |
| Edoxaban | 552 | 10.4K | £17.1K | -21.2% ▼ |
| Naproxen | 536 | 25.9K | £2.5K | -45.7% ▼ |
| Duloxetine hydrochloride | 532 | 13.8K | £1.4K | -16.3% ▼ |
| Lercanidipine hydrochloride | 526 | 13.9K | £1.6K | -14.8% ▼ |
| Mebeverine hydrochloride | 525 | 19.6K | £1.3K | +69.1% ▲ |
| Cetirizine hydrochloride | 519 | 25.4K | £1.4K | +3.9% ▲ |
| Pravastatin sodium | 510 | 9,744 | £498 | +57.0% ▲ |
| Zopiclone | 509 | 11.1K | £484 | -8.1% ▼ |
| Carbocisteine | 505 | 31.5K | £2.0K | -5.4% ▼ |
| Prednisolone | 504 | 22.7K | £917 | -36.9% ▼ |
| Bumetanide | 494 | 8,548 | £865 | +81.3% ▲ |
| Finasteride | 493 | 7,168 | £289 | -24.7% ▼ |
| Ferrous fumarate | 491 | 16.9K | £655 | -32.3% ▼ |
| Alendronic acid | 473 | 1,968 | £459 | -36.9% ▼ |
| Macrogol 3350 | 465 | 20.9K | £3.7K | -50.4% ▼ |
| Estradiol with progestogen | 465 | 11.3K | £6.5K | +36.4% ▲ |
| Quinine sulfate | 459 | 7,497 | £1.3K | +58.5% ▲ |
| Fluoxetine hydrochloride | 457 | 20.3K | £1.1K | -54.9% ▼ |
| Lisinopril | 449 | 14.8K | £2.8K | -59.0% ▼ |
| 447 | 50.9K | £1.9K | -5.8% ▼ | |
| Co-careldopa (Carbidopa/levodopa) | 436 | 17.3K | £1.8K | +92.9% ▲ |
| Melatonin | 430 | 15.7K | £10.0K | +29.3% ▲ |
| Lymecycline | 429 | 7,651 | £910 | +256.7% ▲ |
| Eplerenone | 428 | 6,923 | £902 | +61.4% ▲ |
| Desogestrel | 419 | 35.3K | £1.4K | +5.7% ▲ |
| Lamotrigine | 414 | 18.1K | £1.4K | -29.9% ▼ |
| Senna | 406 | 16.1K | £491 | -32.5% ▼ |
| Co-dydramol (Dihydrocodeine/paracetamol) | 401 | 42.1K | £2.2K | +123.2% ▲ |
| Flucloxacillin sodium | 387 | 13.8K | £855 | -13.9% ▼ |
| Betahistine hydrochloride | 384 | 22.3K | £911 | +60.8% ▲ |
| Rivaroxaban | 376 | 8,505 | £4.8K | -38.5% ▼ |
| Pantoprazole | 367 | 12.1K | £578 | +33.5% ▲ |
| Olmesartan medoxomil | 359 | 8,960 | £362 | +421.1% ▲ |
| Sildenafil (Erectile Dysfunction) | 359 | 2,044 | £294 | -28.8% ▼ |
| Ezetimibe | 358 | 7,588 | £1.4K | -49.7% ▼ |
| Quetiapine | 356 | 10.8K | £9.1K | -42.8% ▼ |
| Mometasone furoate | 345 | 345 | £2.6K | -14.1% ▼ |
| Nitrofurantoin | 342 | 10.3K | £3.1K | -28.3% ▼ |
| Thiamine hydrochloride | 336 | 8,414 | £243 | -36.3% ▼ |
| Trimethoprim | 328 | 8,166 | £445 | +60.5% ▲ |
| Solifenacin | 316 | 7,905 | £315 | -33.8% ▼ |
| Oxycodone hydrochloride | 315 | 15.3K | £4.0K | +23.1% ▲ |
| Sumatriptan succinate | 314 | 3,040 | £616 | -11.3% ▼ |
| Fluticasone propionate (Inhalation) | 312 | 337 | £9.7K | -19.4% ▼ |
| Felodipine | 311 | 9,436 | £1.4K | -47.6% ▼ |
| Promethazine hydrochloride | 311 | 10.5K | £1.5K | -13.0% ▼ |
| Sacubitril/valsartan | 310 | 8,078 | £13.1K | +29.5% ▲ |
| Betamethasone valerate | 308 | 23.7K | £2.0K | -20.0% ▼ |
| Indapamide | 305 | 6,416 | £475 | -64.6% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.